InvestorsHub Logo
icon url

Justfactsmam

12/28/13 11:03 AM

#2560 RE: macnqueso #2556

IMOH...XXII is not a true biotech stock. Its a hybrid. It will have a basic "staples" business with or without FDA, which can flourish elsewhere (outside the U.S.) and quite handsomely.

The biotech aspect is the FDA designation as VLN...which is just a bonus.